Navigation Links
Dyadic International Reports Third Quarter 2013 Financial Results
Date:11/14/2013

eration of this facility in 2014.
  • Sanofi.  Dyadic scientists have successfully purified and delivered a target protein to Sanofi, and we are now finalizing the purification process for the second.  The Company believes that Sanofi has, or will soon begin the pre-clinical testing phase using the delivered protein.
  • In support of its new product development initiative announced in the second quarter, Dyadic is expanding its Netherlands research facility by 40%.  The expansion should be complete by the end of the fourth quarter.  To offset the additional cost, Dyadic is closing its Greensboro, NC laboratory and relocating the capabilities.  In addition, Dyadic took cost reduction actions in IT and with certain external service providers during the quarter.  The full financial impact of these cost reductions will be seen during fiscal year 2014. 

    During the quarter, Dyadic received the approval of its thirteenth patent issued in the U.S. and 54th patent worldwide.  The patent is related to methods of developing and producing a variety of fungal enzymes.  The patent addresses methods to use novel enzymes in a variety of processes, including washing of clothing, detergent processes, bio-refining, de-inking and bio-bleaching of paper and pulp, and treatment of waste streams.

    Financial Results for the Quarter Ended September 30, 2013 vs. September 30, 2012Total revenue for the third quarter increased to $3.5 million compared to $2.5 million for the third quarter last year.  The increase in total revenue as compared to the same period last year was driven by a 55% increase in product related revenue, which was offset by a $211,000 decrease in research and development revenue.

    Net product-related revenue for the third quarter increased to $3.2 million compared to $2.1 million for the third quarter last year.  The increase was attributable to newly added sales chann
    '/>"/>

    SOURCE Dyadic International, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11

    Related biology technology :

    1. Dyadic International Partners with Leading Provider of Nutritional Ingredient Solutions for Production of Food Enzymes
    2. Dyadic International Launches FibreZyme® G5000 High Performance Powder Pulp and Paper Enzyme in Booth #1065 at Tissue World Americas Conference
    3. Dyadic International To Release First Quarter 2012 Financial Results And Host Conference Call
    4. Dyadic Demonstrates Industry-leading Biofuels Enzyme Performance
    5. Dyadic International to Announce Second Quarter 2012 Financial Results and Host Conference Call on Monday, August 13, 2012
    6. Dyadic Netherlands To Develop Baking Enzymes For EU-Funded Research Project
    7. Dyadic International Reports 2012 Third Quarter Financial Results
    8. 12th U.S. Patent Issued To Dyadic International
    9. Dyadic International Upgraded By OTC Markets To "Current Information" Tier
    10. Dyadic International To Announce Year-End 2012 Financial Results And Host Conference Call On Thursday, March 7, 2013
    11. Dyadic International To Present At World Biofuels Markets
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:10/1/2014)... September 30, 2014 Today the ... round of grants for the Brain Research through ... aims to develop and revolutionize new methods of ... the human brain. This first round of grants ... 2014 was allocated to more than 100 investigators ...
    (Date:10/1/2014)... VA (PRWEB) October 01, 2014 ... Diagnostic, Clinical Therapeutics, Healthcare IT, and Laboratory Testing industries, ... regulatory positions at the director level and above from ... struggling to stay on top of rapid breakthroughs in ... result, many diagnostic companies have been forced to fold, ...
    (Date:10/1/2014)... , October 1, 2014 ... software invited to engage around the theme, ,Commercial Opportunities ...   Elsevier , a ... and services, will host a gathering of some of ... and trends impacting healthcare today and in the future. ...
    (Date:9/30/2014)... analog of one of nature,s most efficient light-harvesting ... led by Alejandro Briseno of the University of ... developing long-sought polymer architecture to boost power-conversion efficiency ... devices. , Briseno, with colleagues and graduate ... University and Dresden University of Technology, Germany, report ...
    Breaking Biology Technology:NIH Awards 15 Grants to CHI Members for BRAIN Initiative Research 2NIH Awards 15 Grants to CHI Members for BRAIN Initiative Research 3Slone Partners Meets Growing Demand as Industry Focuses on Reimbursement & Regulation 2Elsevier Healthcare and Pharmaceutical Economics Conference 2014 To Convene Industry Leaders to Discuss Top Healthcare Business Issues 2Elsevier Healthcare and Pharmaceutical Economics Conference 2014 To Convene Industry Leaders to Discuss Top Healthcare Business Issues 3Blades of grass inspire advance in organic solar cells 2Blades of grass inspire advance in organic solar cells 3
    ... England, July 20, 2011 , ... of its randomised, placebo-controlled, double blind Phase II,Study, ... Progressive Multiple Sclerosis (SPMS). Standard clinical,measures and assessment ... as novel biomarkers will be used to investigate ...
    ... 2011 ReSearch Pharmaceutical Services, Inc. (RPS), a ... II-IV clinical development solutions to the biopharmaceutical and ... additions to its Operational and Senior Management team. ... as Chief Information Officer and Executive Vice President, ...
    ... PDL BioPharma, Inc. (PDL) (NASDAQ: ... second quarter financial results for the period ended June 30, 2011, ... will host a conference call and webcast that day at 4:30 ... Conference Call Details To access the live ...
    Cached Biology Technology:Daval International Announces Completion of Phase II Trial for the Treatment of Bladder Dysfunction With AIMSPRO® in Secondary Progressive Multiple Sclerosis 2Daval International Announces Completion of Phase II Trial for the Treatment of Bladder Dysfunction With AIMSPRO® in Secondary Progressive Multiple Sclerosis 3RPS Continues Expansion of Global Clinical, Regulatory, Medical, and Operational Leadership 2RPS Continues Expansion of Global Clinical, Regulatory, Medical, and Operational Leadership 3PDL BioPharma Announces Second Quarter 2011 Financial Results on July 27, 2011 2
    (Date:9/30/2014)... Ill. --- Do we think of nature as something that ... we need to "preserve?" Or do we think of ourselves ... part of nature, but what about a house? , ... are also reflected in our actions, our speech and in ... with the University of Washington, the American Indian Center of ...
    (Date:9/30/2014)... captured the popular attention of both children and aquarium ... sold as dehydrated eggs, these tiny brine shrimp readily ... tank of salt water. , Physicists, though, are ... shrimp vertically migrate in large groups in response to ... night and retreating deeper during the day. , Two ...
    (Date:9/30/2014)... led by Clemson University associate professor Brian Powell, ... the U.S. Department of Energy,s Experimental Program to ... impact on South Carolina in the advancement of ... "Understanding the scientific and engineering needs for safely ... technologies is imperative if South Carolina is to ...
    Breaking Biology News(10 mins):The cultural side of science communication 2Laser-guided sea monkeys show how zooplankton migrations may affect global ocean currents 2Researchers get $5.25 million to advance nuclear technologies in South Carolina 2
    ... 2008) -- Cell Press has been chosen by ... journal from January 2009. The Biophysical Society ... Journal content and that of the Cell Press ... and Structure. , For more than 50 years ...
    ... . , Iron is vital to human life; ... that makes our blood red and supplies our cells with ... thought that iron deposits in the brain contribute to certain ... Alzhiemers. A malfunction of the blood transporter transferrin may be ...
    ... new modeling approach to estimate sea ice thickness. This ... The model was developed by scientists with ... Sciences, Moscow. Using this new technique, the ... to 2003. Results showed that average ice thickness and ...
    Cached Biology News:Cell Press announces new partnership with the Biophysical Society 2Rusty worms in the brain 2New method to estimate sea ice thickness 2
    Request Info...
    Recombinant Rat Leptin, Ultra Pure...
    Lentigen's manufacturing platform is sufficiently versatile for use in the manufacture of any HIV-based Lentiviral vector. Lentigen will manufacture your LV of choice to the highest possible titer a...
    Bethyl Laboratories packages antibodies, conjugates and calibrators to provide quantitative ELISA kits. Each kit contains the following components, sufficient for 1000 single well assays....
    Biology Products: